| P2093 | author name string | W. John Boscardin | |
| | William J. Gordon | |
| | Michael A. Steinman | |
| | Jesse M. Polansky | |
| | Kathy Z. Fung | |
| P2860 | cites work | Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 |
| | Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study | Q24630111 |
| | Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis | Q24679573 |
| | Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 |
| | Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report | Q27861020 |
| | Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis | Q28195576 |
| | General cardiovascular risk profile for use in primary care: the Framingham Heart Study | Q29614189 |
| | Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines | Q29619614 |
| | Presentation of multivariate data for clinical use: The Framingham Study risk score functions | Q30927826 |
| | Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database | Q33867311 |
| | C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study | Q34552689 |
| | Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem | Q34570973 |
| | Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study | Q34683640 |
| | Implications of changing national cholesterol education program goals for the treatment and control of hypercholesterolemia | Q34704310 |
| | Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians | Q34742666 |
| | Assessing the value of risk predictions by using risk stratification tables | Q34969023 |
| | A systematic review and economic evaluation of statins for the prevention of coronary events. | Q36780210 |
| | Benefit/risk ratio of statins in primary prevention | Q36835515 |
| | By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? | Q36884264 |
| | Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures | Q37435521 |
| | US consumer body calls for review of cholesterol guidelines | Q42409042 |
| | Making sense of risk information on the web | Q42948898 |
| | Consequences of using different methods to assess cardiovascular risk in primary care. | Q43553039 |
| | Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation | Q43742848 |
| | New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population | Q43854293 |
| | Low and lowered cholesterol and total mortality | Q45036438 |
| | Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance. | Q45937737 |
| | Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering | Q46111114 |
| | Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events? | Q46549322 |
| | Two approaches of coronary risk assessment--do they work? | Q46975087 |
| | National Cholesterol Education Program risk assessment and potential for risk misclassification | Q57413992 |
| | Multiple imputation of missing blood pressure covariates in survival analysis | Q77327572 |
| | Potential pitfalls of disease-specific guidelines for patients with multiple conditions | Q81213097 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1145-1151 | |
| P577 | publication date | 2010-09-08 | |
| P1433 | published in | Journal of General Internal Medicine | Q6295242 |
| P1476 | title | Coronary risk assessment by point-based vs. equation-based Framingham models: significant implications for clinical care | |
| | Coronary Risk Assessment by Point-Based vs. Equation-Based Framingham Models: Significant Implications for Clinical Care | |
| P478 | volume | 25 | |